Evvy, a women's health company focused on vaginal microbiome research, has raised $40 million in a Series B funding round led by Catalio Capital Management. The funding will support further research into women's health through vaginal microbiome data collection and analysis.
Background
Evvy is known for its at-home vaginal microbiome testing kits, enabling women to track their reproductive health over time. The company has been building a large database of vaginal microbiome data to advance women's health research.
- Source
- TechCrunch
- Published
- Sep 15, 2026 at 10:13 PM
- Score
- 5.0 / 10